Schiavone, Carmine (2025) Scale-Up from Individuals to Populations: Process-Aware Optimization of Antibody Durability and Boosting. [Tesi di dottorato]
|
Documento PDF
CarmineSchiavone_PhD.pdf Visibile a [TBR] Amministratori dell'archivio Download (5MB) |
| Tipologia del documento: | Tesi di dottorato |
|---|---|
| Lingua: | English |
| Titolo: | Scale-Up from Individuals to Populations: Process-Aware Optimization of Antibody Durability and Boosting |
| Autori: | Autore Email Schiavone, Carmine carmineschuni@gmail.com |
| Data: | 31 Ottobre 2025 |
| Numero di pagine: | 168 |
| Istituzione: | Università degli Studi di Napoli Federico II |
| Dottorato: | Ingegneria dei prodotti e dei processi industriali |
| Ciclo di dottorato: | 38 |
| Coordinatore del Corso di dottorato: | nome email D'Anna, Andrea andrea.danna@unina.it |
| Tutor: | nome email Sergio, Caserta [non definito] |
| Data: | 31 Ottobre 2025 |
| Numero di pagine: | 168 |
| Parole chiave: | Vaccine, Mathematical modeling, PKPD, QSP |
| Settori scientifico-disciplinari del MIUR: | Area 09 - Ingegneria industriale e dell'informazione > ING-IND/24 - Principi di ingegneria chimica |
| Informazioni aggiuntive: | Ciclo 38esimo |
| Depositato il: | 26 Gen 2026 10:59 |
| Ultima modifica: | 12 Ago 2026 05:39 |
| URI: | https://www.fedoa.unina.it/id/eprint/17112 |
Abstract
Vaccination averts millions of deaths, but protection wanes and varies by variant, age, and immune competence. This thesis links within‑host immunodynamics to dosing policy to minimize vulnerability windows—the time antibody titers fall below efficacy‑relevant thresholds. We develop a mechanistic model of antigen presentation, T follicular helper mediated germinal‑center selection and affinity maturation, plasma‑cell (short‑lived and long‑lived) generation, and neutralizing IgG kinetics, calibrated to longitudinal datasets. We then perform schedule optimization over primary dose spacing and booster timing to balance near‑term coverage against maturation, stratified by immune status (healthy, mildly, highly immuno-compromised). At the individual level, early post‑dose titers inform compact parameter sets that predict peak magnitude and durability, enabling phenotype‑aware recommendations. Finally, individual parameter distributions are propagated through between‑host transmission models to compare phenotype‑aware boosting with coarse health‑factor rules, preferentially targeting weak responders while conserving doses in strong responders.
Downloads
Downloads per month over past year
Actions (login required)
![]() |
Modifica documento |


